Resonance Health Limited (ASX:RHT)
Australia
· Delayed Price · Currency is AUD 0.0400
0.00 (0.00%)
At close: Mar 6, 2026
Resonance Health Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Operating Revenue | 13.84 | 11.07 | 8.59 | 4.4 | 3.83 | 3.78 | Upgrade
|
| Other Revenue | -0.05 | - | - | - | 0.03 | - | Upgrade
|
| Revenue | 13.79 | 11.07 | 8.59 | 4.4 | 3.85 | 3.78 | Upgrade
|
| Revenue Growth (YoY) | 30.17% | 28.91% | 95.02% | 14.31% | 1.96% | 3.02% | Upgrade
|
| Gross Profit | 13.79 | 11.07 | 8.59 | 4.4 | 3.85 | 3.78 | Upgrade
|
| Selling, General & Admin | 10.32 | 9.88 | 7.37 | 4.19 | 3.76 | 2.38 | Upgrade
|
| Research & Development | 0.7 | 0.96 | 0.84 | 0.71 | 0.72 | 0.39 | Upgrade
|
| Amortization of Goodwill & Intangibles | 0.5 | 0.52 | 0.26 | 0.3 | 0.31 | 0.29 | Upgrade
|
| Other Operating Expenses | 0.96 | 0.85 | 0.42 | 0.43 | 0.47 | 0.24 | Upgrade
|
| Operating Expenses | 12.88 | 12.66 | 9.12 | 5.76 | 5.38 | 3.38 | Upgrade
|
| Operating Income | 0.91 | -1.58 | -0.53 | -1.36 | -1.52 | 0.4 | Upgrade
|
| Interest Expense | -0.33 | -0.32 | -0.05 | - | - | - | Upgrade
|
| Interest & Investment Income | 0.04 | 0.04 | 0.14 | 0.04 | 0 | 0.04 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.07 | 0.04 | 0.04 | 0.29 | 0.19 | -0.09 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.26 | -0.3 | -0.23 | -0.2 | -0.22 | -0.01 | Upgrade
|
| EBT Excluding Unusual Items | 0.29 | -2.12 | -0.63 | -1.23 | -1.55 | 0.34 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.08 | -0.08 | - | - | - | - | Upgrade
|
| Asset Writedown | - | - | - | -0.03 | - | - | Upgrade
|
| Pretax Income | 0.22 | -2.2 | -0.63 | -1.26 | -1.55 | 0.34 | Upgrade
|
| Income Tax Expense | -0.55 | -0.47 | -0.8 | -0.48 | -0.41 | -0.24 | Upgrade
|
| Net Income | 0.77 | -1.73 | 0.17 | -0.78 | -1.14 | 0.59 | Upgrade
|
| Net Income to Common | 0.77 | -1.73 | 0.17 | -0.78 | -1.14 | 0.59 | Upgrade
|
| Shares Outstanding (Basic) | 467 | 455 | 456 | 461 | 461 | 450 | Upgrade
|
| Shares Outstanding (Diluted) | 474 | 455 | 468 | 461 | 461 | 452 | Upgrade
|
| Shares Change (YoY) | 5.65% | -2.81% | 1.59% | - | 1.97% | 4.59% | Upgrade
|
| EPS (Basic) | 0.00 | -0.00 | 0.00 | -0.00 | -0.00 | 0.00 | Upgrade
|
| EPS (Diluted) | 0.00 | -0.00 | 0.00 | -0.00 | -0.00 | 0.00 | Upgrade
|
| Free Cash Flow | 0.05 | 0.81 | 1.16 | -0.45 | -1.57 | 1.13 | Upgrade
|
| Free Cash Flow Per Share | - | 0.00 | 0.00 | -0.00 | -0.00 | 0.00 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | 6.62% | -14.30% | -6.16% | -30.89% | -39.57% | 10.58% | Upgrade
|
| Profit Margin | 5.58% | -15.65% | 1.97% | -17.72% | -29.63% | 15.50% | Upgrade
|
| Free Cash Flow Margin | 0.34% | 7.27% | 13.48% | -10.11% | -40.86% | 29.86% | Upgrade
|
| EBITDA | 1.1 | -1.41 | -0.41 | -1.32 | -1.49 | 0.42 | Upgrade
|
| EBITDA Margin | 7.95% | -12.72% | -4.77% | -29.96% | -38.69% | 11.09% | Upgrade
|
| D&A For EBITDA | 0.18 | 0.18 | 0.12 | 0.04 | 0.03 | 0.02 | Upgrade
|
| EBIT | 0.91 | -1.58 | -0.53 | -1.36 | -1.52 | 0.4 | Upgrade
|
| EBIT Margin | 6.62% | -14.30% | -6.16% | -30.89% | -39.57% | 10.58% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.